Skip to main content
SpringerLink
Log in

Uterine Sarcomas: Risk Factors, Clinical Presentation, Diagnosis, and Staging

  • Chapter
Uterine Cancer

Abstract

Mesenchymal tumors of the uterine corpus are rare, accounting for approximately 7–8 % of all uterine cancers [1]. As per The American cancer society’s estimates for cancer of uterine corpus in the USA for 2014, about 52,630 new cases of cancer of the uterine corpus will be diagnosed, but only about 1,600 (3 %) of these cases will be uterine sarcomas [1, 2]. In stark contrast, a registry from a tertiary centre in north India has shown that uterine sarcomas constitutes roughly 25 % of all uterine malignancies [3]. There has also been a rise in the incidence of uterine malignancies in the Indian subcontinent in the past decade [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D’ Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131–9.

    Article  Google Scholar 

  2. Doss LL, Llorens AS, Henriquez EM. Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri. Gynecol Oncol. 1984;18:43–53.

    Article  CAS  PubMed  Google Scholar 

  3. Rajaram S, Malik R, Agarwal S, Suneja A. The role of hospital-based cancer registries in low and middle income countries-Indian statistics. Cancer Epidemiol. 2013;37(1):e7.

    Article  PubMed  Google Scholar 

  4. Agarwal S, Malhotra KP, Sinha S, Rajaram S. Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade: comparative evaluation with international data. Indian J Cancer. 2012;49(3):298–302.

    Article  CAS  PubMed  Google Scholar 

  5. Trop É CG, Abeler MV. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012;51:694–705.

    Article  Google Scholar 

  6. Shah SH, Jagannathan JP, Krajewski K, O’Regan KN, George S, Ramaiya NH. Uterine sarcomas: then and now. Am J Roentgenol. 2012;199:213–23.

    Article  Google Scholar 

  7. McCluggage WG. Malignant biphasic uterine tumours: carcinosarcoma or metaplastic carcinomas? J Clin Pathol. 2002;55:321–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Zelmanowicz A, Hildesheim A, Sherman ME, et al. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol. 1998;69(3):253.

    Article  CAS  PubMed  Google Scholar 

  9. Park J, Kim D, Suh D, et al. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007. J Cancer Res Clin Oncol. 2008;134:1277–87.

    Article  PubMed  Google Scholar 

  10. Abeler VM, R ø yne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009;54:355–64.

    Article  PubMed  Google Scholar 

  11. Giuntoli RL, Metzinger DS, Dimarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89:460–9.

    Article  PubMed  Google Scholar 

  12. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer. 2006;119:2922–30.

    Article  CAS  PubMed  Google Scholar 

  13. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93:204–8.

    Article  PubMed  Google Scholar 

  14. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer. 2003;3:685–94.

    Article  CAS  PubMed  Google Scholar 

  15. Hiroshi K, Chiaki U, Juria A, et al. The biology of uterine sarcomas: a review and update. Mol Clin Oncol. 2013;1:599–609.

    Google Scholar 

  16. Lee C, Ou W, Marino-Enriquez A, et al.14-3-3 fusion oncogenes in high grade endometrial stromal sarcoma. PNAS. 2012;109:929–34.

    Google Scholar 

  17. Hayashi T, Kobayashi Y, Kohsaka S, Sano K. The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2. Oncogene. 2006;25:4016–26.

    Article  CAS  PubMed  Google Scholar 

  18. Saegusa M, Hashimura M, Kuwata T, et al. Requirement of Akt/ b-catenin pathway for uterine carcinosarcoma genesis, modulating E-catherin expression through the transactivation of slug. Am J Pathol. 2009;174:2107–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Guntupali SR, Ramirez PT, Anderson ML, et al. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113:324–6.

    Article  Google Scholar 

  20. Christopherson WM, Williamson EO, Gray LA. Leiomyosarcoma of the uterus. Cancer. 1972;29:1512–7.

    Article  CAS  PubMed  Google Scholar 

  21. Norris HJ, Roth E, Taylor HB. Mesenchymal tumors of the uterus. Obstet Gynecol. 1966;28:57–63.

    CAS  PubMed  Google Scholar 

  22. Meredith RJ, Eisert DR, Kaka Z, et al. An excess of uterine sarcomas after pelvic irradiation. Cancer. 1986;58:2003–7.

    Google Scholar 

  23. Pothuri B, Ramondetta L, Eifel P, et al. Radiation associated endometrial cancers are prognostically unfavourable tumours: a clinicopathologic comparison with 527 sporadic endometrial cancers. Gynecol Oncol. 2006;103:948–51.

    Article  PubMed  Google Scholar 

  24. Jaakkola S, Lyytinen HK, Pukkala E, et al. Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas. Gynecol Oncol. 2011;122:260–3.

    Article  CAS  PubMed  Google Scholar 

  25. Hoogendoorern WE, Hollema H, Van Boven HH, et al. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer. Breast Cancer Res Treat. 2008;112:99–108.

    Article  Google Scholar 

  26. Nilbert M, Therkildsen C, Nissen A, et al. Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum. Fam Cancer. 2009;8:209–13.

    Article  PubMed  Google Scholar 

  27. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet. 2005;161:1–19.

    Article  PubMed  Google Scholar 

  28. Dos Santos LA, Garg K, Diaz JP, et al. Incidence of lymph nodes and adnexal metastasis in endometrial stromal sarcoma. Gynecol Oncol. 2011;121:319–22.

    Article  PubMed  Google Scholar 

  29. Bansal N, Herzog TJ, Burke W, Cohen CJ, Wright JD. The utility of preoperative endometrial sampling for the detection of endometrial sarcomas. Gynecol Oncol. 2008;110:43–8.

    Article  PubMed  Google Scholar 

  30. Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early stage uterine sarcoma. Cancer. 1993;71:1702–9.

    Article  CAS  PubMed  Google Scholar 

  31. Goto A, Takeuchi S, Sugimura K, et al. Usefulness of Gd-DTPA contrast enhanced dynamic MRI and serum determination of LDH and its isizymes in differential diagnosis of leiomyosarcoma from degenerated leiomyomaof the uterus. Int J Gynecol Cancer. 2002;12:354–61.

    Article  CAS  PubMed  Google Scholar 

  32. Lim D, Wang WL, Lee CH, et al. Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: a study of 86 cases. Gynecol Oncol. 2013;128:322–6.

    Article  CAS  PubMed  Google Scholar 

  33. Zivanovic O, Jacks LM, Iasonos A, Leitao Jr MM, Soslow RA, Veras E, et al. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer. 2012;118:660–9.

    Article  PubMed  Google Scholar 

  34. Wang WL, Soslow R, Hensley M, Asad H, Zannoni GF, de Nictolis M, et al. Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases. Am J Surg Pathol. 2011;35:522–9.

    Article  PubMed  Google Scholar 

  35. Garg G, Shah JP, Kumar S, Bryant CS, Munkarah A, Morris RT. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer. 2010;20:888–94.

    Article  PubMed  Google Scholar 

  36. Tan PS, Koh E, Pang C, Ong WS, Ngo L, Soh LT, et al. Uterine leiomyosarcoma in Asian patients: validation of the revised federation of gynecology and obstetrics staging system and identification of prognostic classifiers. Oncologist. 2012;17:1286–93.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Silverberg SG, Major FJ, Blessing JA, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases. Int J Gynecol Pathol. 1990;9:1–19.

    Article  CAS  PubMed  Google Scholar 

  38. Kaku T, Silverberg SG, Major FJ, et al. Adenosarcoma of the uterus: a gynecologic oncology group clinicopathologic study of 31 cases. Int J Gynecol Pathol. 1992;11:75–88.

    Article  CAS  PubMed  Google Scholar 

  39. Nordal RN, Kjørstad KE, Stenwig AE, Tropé CG. Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian radium hospital 1976–1985. Int J Gynecol Cancer. 1993;3:110–5.

    Article  PubMed  Google Scholar 

  40. Nordal RR. Uterine sarcomas in Norway 1956–1992: an epidemiological and clinicopathological study. A thesis. Oslo: Faculty of Medicine – University of Oslo; 1998.

    Google Scholar 

  41. Perry T, Korach J, Sadetzki S, et al. Uterine leimyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer. 2009;19:257–60.

    Article  Google Scholar 

  42. Park J, Park S, Kim D, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol. 2011;18:3453–61.

    Article  PubMed  Google Scholar 

  43. Fox H. Ploidy in gynaecological cancers. Histopathology. 2005;46:121–9.

    Article  CAS  PubMed  Google Scholar 

  44. Kildal W, Abeler VM, Kristensen GB, Jenstad M, Thoresen SØ, Danielsen HE. The prognostic value of DNA ploidy in a total population of uterine sarcomas. Ann Oncol. 2009;20:1037–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, Gujarat Cancer Research Institute (GCRI), Ahmedabad, Gujarat, India

    Monisha Gupta MS (Fellowship Gyne Oncology (TMH, Mumbai), Assistant Professor)

  2. Department of Obstetrics & Gynecology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India

    Shalini Rajaram MD, FAMS

Authors
  1. Monisha Gupta MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shalini Rajaram MD, FAMS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shalini Rajaram MD, FAMS .

Editor information

Editors and Affiliations

  1. Obstetrics and Gynecology, University College of Medical Sciences, New Delhi, India

    Shalini Rajaram

  2. Surgical &Gynec Oncology, Lakeshore & Welcare Hospitals, Kochi, Kerala, India

    Chitrathara K

  3. Gynec Onclogy, Tata Memorial Hospital, Mumbai, India

    Amita Maheshwari

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Gupta, M., Rajaram, S. (2015). Uterine Sarcomas: Risk Factors, Clinical Presentation, Diagnosis, and Staging. In: Rajaram, S., K, C., Maheshwari, A. (eds) Uterine Cancer. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1892-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1892-0_30

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1891-3

  • Online ISBN: 978-81-322-1892-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation